β-secretase expression in normal and functionally deprived rat olfactory bulbs: Inverse correlation with oxidative metabolic activity

Journal of Comparative Neurology

Volumn 501, Issue 1, 2007, Pages 52-69

  Yan, Xiao Xin ^a   Xiong, Kun ^a,b   Luo, Xue Gang ^b   Struble, Robert G ^a   Clough, Richard W ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

amyloid; Aging; Alzheimer's disease; Hypometabolism; Mitochondria, dementia; Neuroplasticity

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; CYTOCHROME C OXIDASE; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME MECHANISM; ENZYME METABOLISM; ENZYME REGULATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NERVE CELL PLASTICITY; NERVE ENDING; NEUROANATOMY; NONHUMAN; OLFACTORY BULB; OLFACTORY SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RAT; REGULATORY MECHANISM; SYNAPSE;

AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BLOTTING, WESTERN; CYTOCHROME-C PEROXIDASE; GLYCOSYLATION; IMMUNOHISTOCHEMISTRY; MALE; NASAL OBSTRUCTION; OLFACTORY BULB; OXIDATION-REDUCTION; PRESENILINS; RATS; RATS, SPRAGUE-DAWLEY; SUCCINATE DEHYDROGENASE; TISSUE DISTRIBUTION; UP-REGULATION;

EID: 33846523416     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21239     Document Type: Article

References (65)

1. Adlard PA, Perreau VM, Pop V, Cotman CW. 2005. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci 25:4217-4221.
2. Bacon AW, Bondi MW, Salmon DP, Murphy C. 1998. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Ann N Y Acad Sci 855:723-731.
3. Blasko I, Beer R, Bigl M, Apelt J, Franz G, Rudzki D, Ransmayr G, Kampfl A, Schliebs R. 2004. Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer's disease beta-secretase (BACE-1). J Neural Transm 111:523-536.
4. Braak H, Braak E. 1996. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl 165:3-12.
5. Caille I, Allinquant B, Dupont E, Bouillot C, Langer A, Muller U, Prochiantz A. 2004. Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone. Development 131:2173-2181.
6. Capell A, Steiner H, Willem M, Kaiser H, Meyer C, Walter J, Lammich S, Multhaup G, Haass C. 2000. Maturation and pro-peptide cleavage of beta-secretase. J Biol Chem 275:30849-30854.
7. Cho JY, Min N, Franzen L, Baker H. 1996. Rapid down-regulation of tyrosine hydroxylase expression in the olfactory bulb of naris-occluded adult rats. J Comp Neurol 369:264-276.
8. Christen-Zaech S, Kraftsik R, Pillevuit O, Kiraly M, Martins R, Khalili K, Miklossy J. 2003. Early olfactory involvement in Alzheimer's disease. Can J Neurol Sci 30:20-25.
9. Clarris HJ, Key B, Beyreuther K, Masters CL, Small DH. 1995. Expression of the amyloid protein precursor of Alzheimer's disease in the developing rat olfactory system. Brain Res Dev Brain Res 88:87-95.
10. Costa DA, Cracchiolo JR, Bachstetter AD, Hughes TF, Bales KR, Paul SM, Mervis RF, Arendash GW, Potter H. 2006. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiol Aging [E-pub ahead of print].
11. Cullinan WE, Brunjes PC. 1987. Unilateral odor deprivation: effects on the development of staining for olfactory bulb succinate dehydrogenase. Brain Res 432:35-42.
12. Cummings DM, Brunjes PC. 1997. The effects of variable periods of functional deprivation on olfactory bulb development in rats. Exp Neurol 148:360-366.
13. Desire L, Bourdin J, Loiseau N, Peillon H, Picard V, De Oliveira C, Bachelot F, Leblond B, Taverne T, Beausoleil E, Lacombe S, Drouin D, Schweighoffer F. 2005. RAC1 inhibition targets amyloid precursor protein processing by gamma-secretase and decreases Abeta production in vitro and in vivo. J Biol Chem 280:37516-3725.
14. Drzezga A, Riemenschneider M, Strassner B, Grimmer T, Peller M, Knoll A, Wagenpfeil S, Minoshima S, Schwaiger M, Kurz A. 2005. Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology 64:102-107.
15. Ferreyra-Moyano H, Barragan E. 1989. The olfactory system and Alzheimer's disease. Int J Neurosci 49:157-197.
16. Fukumoto H, Cheung BS, Hyman BT, Irizarry MC. 2002. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 59:1381-1389.
17. Fukumoto H, Rosene DL, Moss MB, Raju S, Hyman BT, Irizarry MC. 2004. Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am J Pathol 164:719-725.
18. Furukawa K, Sopher BL, Rydel RE, Begley JG, Pham DG, Martin GM, Fox M, Mattson MP. 1996. Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J Neurochem 67:1882-1896.
19. Gandhi S, Refolo LM, Sambamurti K. 2004. Amyloid precursor protein compartmentalization restricts beta-amyloid production: therapeutic targets based on BACE compartmentalization. J Mol Neurosci 24:137-143.
20. Gibson GE, Huang HM. 2005. Oxidative stress in Alzheimer's disease. Neurobiol Aging 26:575-578.
21. Hawkes C. 2003. Olfaction in neurodegenerative disorder. Mov Disord 18:364-372.
22. Hevner RF, Liu S, Wong-Riley MT. 1995. A metabolic map of cytochrome oxidase in the rat brain: histochemical, densitometric and biochemical studies. Neuroscience 65:313-342.
23. Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G. 2002. Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Ann Neurol 51:783-786.
24. Huse JT, Pijak DS, Leslie GJ, Lee VM, Doms RW. 2000. Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase. J Biol Chem 275:33729-33737.
25. Jankowsky JL, Xu G, Fromholt D, Gonzales V, Borchelt DR. 2003. Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol 62:1220-1227.
26. Jin BK, Franzen L, Baker H. 1996. Regulation of c-Fos mRNA and fos protein expression in olfactory bulbs from unilaterally odor-deprived adult mice. Int J Dev Neurosci 14:971-982.
27. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R. 2003. APP processing and synaptic function. Neuron 37:925-937.
28. Kasowski HJ, Kim H, Greer CA. 1999. Compartmental organization of the olfactory bulb glomerulus. J Comp Neurol 407:261-274.
29. Kern A, Roempp B, Prager K, Walter J, Behl C. 2006. Down-regulation of endogenous amyloid precursor protein processing due to cellular aging. J Biol Chem 281:2405-2413.
30. Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, Smith GE, Dickson DW, Johnson KA, Petersen LE, McDonald WC, Braak H, Petersen RC. 2003. Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 62:1087-1095.
31. Kovacs T, Cairns NJ, Lantos PL. 2001. Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport 12:285-288.
32. Kuhl DE, Metter EJ, Riege WH, Hawkins RA. 1984. The effect of normal aging on patterns of local cerebral glucose utilization. Ann Neurol 15:S133-137.
33. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mimics K, Sisodia SS. 2005. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120:701-713.
34. Lesnefsky EJ, Hoppel CL. 2006. Oxidative phosphorylation and aging. Ageing Res Rev 5:402-433.
35. Lledo PM, Alonso M, Grubb MS. 2006. Adult neurogenesis and functional plasticity in neuronal circuits. Nat Rev Neurosci 7:179-193.
36. R, Lindholm K, Yang LB, Yue X, Citron M, Yan R, Beach T, Sue L, Sabbagh M, Cai H, Wong P, Price D, Shen Y. 2004. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Proc Natl Acad Sci U S A 101:3632-3637.
37. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, Wu H. 2004. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304:448-452.
38. Mosconi L. 2005. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32:486-510.
39. Najbauer J, Yan XX, Leon M. 2002. Internucleosomal DNA fragmentation during deprived and non-deprived olfactory development. Brain Res 926:118-125.
40. Nestor PJ, Fryer TD, Smielewski P, Hodges JR. 2003. Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann Neurol 54:343-351.
41. Nistor M, Don M, Parekh M, Sarsoza F, Goodus M, Lopez GE, Kawas C, Leverenz J, Doran E, Lott IT, Hill M, Head E. 2006. Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain. Neurobiol Aging [E-pub ahead of print].
42. Nitsch RM, Growdon JH. 1994. Role of neurotransmission in the regulation of amyloid beta-protein precursor processing. Biochem Pharmacol 47:1275-1284.
43. Ojaimi J, Masters CL, Opeskin K, McKelvie P, Byrne E. 1999. Mitochondrial respiratory chain activity in the human brain as a function of age. Mech Ageing Dev 111:39-47.
44. Peters JM, Hummel T, Kratzsch T, Lotsch J, Skarke C, Frolich L. 2003. Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques. Am J Psychiatry 160:1995-2002.
45. Philpot BD, Foster TC, Brunjes PC. 1997. Mitral/tufted cell activity is attenuated and becomes uncoupled from respiration following naris closure. J Neurobiol 33:374-386.
46. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J. 2005. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci U S A 102:8299-8302.
47. Roberts E. 1986. Alzheimer's disease may begin in the nose and may be caused by aluminosilicates. Neurobiol Aging 7:561-567.
48. Samudralwar DL, Diprete CC, Ni BF, Ehmann WD, Markesbery WR. 1995. Elemental imbalances in the olfactory pathway in Alzheimer's disease. J Neurol Sci 130:139-145.
49. Selkoe DJ. 2000. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci 924:17-25.
50. Sidera C, Parsons R, Austen B. 2005. Post-translational processing of beta-secretase in Alzheimer's disease. Proteomics 5:1533-1543.
51. Struble RG, Clark HB. 1992. Olfactory bulb lesions in Alzheimer's disease. Neurobiol Aging 13:469-473.
52. Struble RG, Dhanraj DN, Mei Y, Wilson M, Wang R, Ramkumar V. 1998. Beta-amyloid precursor protein-like immunoreactivity is up-regulated during olfactory nerve regeneration in adult rats. Brain Res 780:129-137.
53. Swerdlow RH, Khan SM. 2004. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. Med Hypoth 63:8-20.
54. ter Laak HJ, Renkawek K, van Workum FP. 1994. The olfactory bulb in Alzheimer disease: a morphologic study of neuron loss, tangles, and senile plaques in relation to olfaction. Alzheimer Dis Assoc Disord 8:38-48.
55. Tong Y, Zhou W, Fung V, Christensen MA, Qing H, Sun X, Song W. 2005. Oxidative stress potentiates BACE1 gene expression and Abeta generation. J Neural Transm 112:455-469.
56. Tyler SJ, Dawbarn D, Wilcock GK, Allen SJ. 2002. Alpha- and beta-secretase: profound changes in Alzheimer's disease. Biochem Biophys Res Commun 299:373-376.
57. Valla J, Berndt JD, Gonzalez-Lima F. 2001. Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration. J Neurosci 21:4923-4930.
58. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M. 1999. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735-741.
59. Velliquette RA, O'Connor T, Vassar R. 2005. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. J Neurosci 25:10874-10883.
60. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. 2002. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535-539.
61. Wen Y, Onyewuchi O, Yang S, Liu R, Simpkins JW. 2004. Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res 1009:1-8.
62. Wong PC, Price DL, Cai H. 2001. The brain's susceptibility to amyloid plaques. Science 293:1434.
63. Wong-Riley M, Antuono P, Ho KC, Egan R, Hevner R, Liebl W, Huang Z, Rachel R, Jones J. 1997. Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems. Vis Res 37:3593-3608.
64. Yan XX, Li T, Rominger CM, Prakash SR, Wong PC, Olson RE, Zaczek R, Li YW. 2004. Binding sites of gamma-secretase inhibitors in rodent brain: distribution, postnatal development, and effect of deafferentation. J Neurosci 24:2942-2952.
65. Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, Beach T, Sue L, Wong P, Price D, Li R, Shen Y. 2003. Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9:3-4.